38,052 XNAS Volume
XNAS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 10,732 | 10,732 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 10,732 | 10,732 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Mathiesen | Director, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 139,857 | 139,857 | - | - | Stock Option (Right to Buy) | |
| Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 10,732 | 10,732 | - | - | Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 279,715 | 279,715 | - | - | Stock Option (Right to Buy) | |
| Sherrie L. Perkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 10,732 | 10,732 | - | - | Stock Option (Right to Buy) | |
| Antonella R. Favit-Van Pelt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 95,892 | 95,892 | - | - | Stock Option (Right to Buy) | |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Mathiesen | Director, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 404,000 | 404,000 | - | - | Stock Option (Right to Buy) | |
| Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 808,000 | 808,000 | - | - | Stock Option (Right to Buy) | |
| Sherrie L. Perkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 31,000 | 31,000 | - | - | Stock Option (Right to Buy) | |
| Antonella R. Favit-Van Pelt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 277,000 | 277,000 | - | - | Stock Option (Right to Buy) | |
| C. Andreeff Dane | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.09 per share. | 14 Dec 2023 | 570 | 3,402 (0%) | 0% | 8.1 | 4,614 | Common Stock |
| C. Andreeff Dane | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.09 per share. | 14 Dec 2023 | 1,603 | 12,879 (0%) | 0% | 8.1 | 12,976 | Common Stock |
| Andreeff Dane C. | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.10 per share. | 14 Dec 2023 | 2,827 | 16,512 (0%) | 0% | 8.1 | 22,885 | Common Stock |
| Andreeff C. Dane | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.45 per share. | 30 Nov 2023 | 643 | 11,276 (0%) | 0% | 6.4 | 4,146 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.45 per share. | 30 Nov 2023 | 1,134 | 13,685 (0%) | 0% | 6.4 | 7,312 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.37 per share. | 30 Nov 2023 | 1,131 | 12,551 (0%) | 0% | 6.4 | 7,205 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.45 per share. | 30 Nov 2023 | 229 | 2,832 (0%) | 0% | 6.4 | 1,477 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.37 per share. | 30 Nov 2023 | 228 | 2,603 (0%) | 0% | 6.4 | 1,452 | Common Stock |
| Dane Andreeff C. | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.37 per share. | 30 Nov 2023 | 641 | 10,633 (0%) | 0% | 6.4 | 4,083 | Common Stock |
| C. Dane Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.37 per share. | 30 Nov 2023 | 641 | 1,239 (0%) | 0% | 6.4 | 4,083 | Common Stock |
| C. Dane Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.45 per share. | 30 Nov 2023 | 643 | 1,882 (0%) | 0% | 6.4 | 4,146 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.37 per share. | 28 Aug 2023 | 2,688 | 8,774 (0%) | 0% | 6.4 | 17,118 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.65 per share. | 28 Aug 2023 | 141 | 599 (0%) | 0% | 7.6 | 1,078 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.64 per share. | 28 Aug 2023 | 1,658 | 9,992 (0%) | 0% | 7.6 | 12,671 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.64 per share. | 28 Aug 2023 | 555 | 2,375 (0%) | 0% | 7.6 | 4,241 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 7.64 per share. | 28 Aug 2023 | 2,646 | 11,420 (0%) | 0% | 7.6 | 20,222 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.37 per share. | 28 Aug 2023 | 143 | 458 (0%) | 0% | 6.4 | 911 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.37 per share. | 28 Aug 2023 | 1,684 | 8,334 (0%) | 0% | 6.4 | 10,724 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 6.37 per share. | 28 Aug 2023 | 563 | 1,820 (0%) | 0% | 6.4 | 3,585 | Common Stock |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 284,865 | 284,865 | - | - | Stock Option (Right to Buy) | |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 83,054 | 93,454 (0%) | 0% | 0 | Class A Common Stock | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 284,865 | 284,865 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 83,054 | 90,111 (0%) | 0% | 0 | Class A Common Stock | |
| Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 284,865 | 284,865 | - | - | Stock Option (Right to Buy) | |
| Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 83,054 | 89,824 (0%) | 0% | 0 | Class A Common Stock | |
| Sherrie L. Perkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 83,054 | 90,040 (0%) | 0% | 0 | Class A Common Stock | |
| Sherrie L. Perkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 284,865 | 284,865 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Mathiesen | Director, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 2,693,000 | 2,693,000 | - | - | Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 5,181,000 | 5,181,000 | - | - | Stock Option (Right to Buy) | |
| Antonella R. Favit-Van Pelt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 1,463,000 | 1,463,000 | - | - | Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 16 Dec 2022 | 2,313 | 15,752 (0%) | 0% | 0.2 | 576 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 16 Dec 2022 | 25,594 | 332,517 (1%) | 0% | 0.2 | 6,378 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 16 Dec 2022 | 8,868 | 62,893 (0%) | 0% | 0.2 | 2,210 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 16 Dec 2022 | 43,266 | 304,323 (0%) | 0% | 0.2 | 10,782 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.28 per share. | 22 Nov 2022 | 10,300 | 218,872 (0%) | 0% | 0.3 | 2,919 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.31 per share. | 22 Nov 2022 | 42,185 | 261,057 (0%) | 0% | 0.3 | 13,149 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.31 per share. | 22 Nov 2022 | 2,509 | 13,439 (0%) | 0% | 0.3 | 782 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.31 per share. | 22 Nov 2022 | 30,841 | 306,923 (0%) | 0% | 0.3 | 9,613 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.31 per share. | 22 Nov 2022 | 10,105 | 54,025 (0%) | 0% | 0.3 | 3,150 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.34 per share. | 16 Nov 2022 | 53,753 | 208,572 (0%) | 0% | 0.3 | 18,195 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.34 per share. | 16 Nov 2022 | 3,049 | 10,930 (0%) | 0% | 0.3 | 1,032 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.34 per share. | 16 Nov 2022 | 37,464 | 276,082 (0%) | 0% | 0.3 | 12,682 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.34 per share. | 16 Nov 2022 | 12,275 | 43,920 (0%) | 0% | 0.3 | 4,155 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.32 per share. | 16 Nov 2022 | 10,000 | 154,819 (0%) | 0% | 0.3 | 3,224 | Common Stock |
| Jeffrey S. Mathiesen | Director, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2022 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Antonella R. Favit-Van Pelt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2022 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 86,000 | 86,000 | - | - | Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.54 per share. | 12 Sep 2022 | 4,752 | 144,819 (0%) | 0% | 0.5 | 2,587 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.54 per share. | 12 Sep 2022 | 1,014 | 31,645 (0%) | 0% | 0.5 | 552 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.54 per share. | 12 Sep 2022 | 2,838 | 88,618 (0%) | 0% | 0.5 | 1,545 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 12 Sep 2022 | 264 | 7,881 (0%) | 0% | 0.5 | 144 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.53 per share. | 12 Sep 2022 | 150,000 | 238,618 (0%) | 0% | 0.5 | 80,205 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 24 Aug 2022 | 13,503 | 99,985 (0%) | 0% | 0.6 | 8,776 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.63 per share. | 24 Aug 2022 | 2,231 | 7,617 (0%) | 0% | 0.6 | 1,406 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.63 per share. | 24 Aug 2022 | 23,937 | 85,780 (0%) | 0% | 0.6 | 15,080 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.63 per share. | 24 Aug 2022 | 8,550 | 30,631 (0%) | 0% | 0.6 | 5,387 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.63 per share. | 24 Aug 2022 | 40,082 | 140,067 (0%) | 0% | 0.6 | 25,252 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 24 Aug 2022 | 752 | 5,386 (0%) | 0% | 0.7 | 489 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 24 Aug 2022 | 8,064 | 61,843 (0%) | 0% | 0.6 | 5,241 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.65 per share. | 24 Aug 2022 | 2,881 | 22,081 (0%) | 0% | 0.6 | 1,872 | Common Stock |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 21,605 | 21,605 | - | - | Stock Option (Right to Buy) | |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 6,049 | 9,400 (0%) | 0% | 0 | Class A Common Stock | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 6,049 | 7,057 (0%) | 0% | 0 | Class A Common Stock | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 21,605 | 21,605 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Mathiesen | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 37,000 | 37,000 | - | - | Stock Option (Right to Buy) | |
| Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 6,049 | 6,770 (0%) | 0% | 0 | Class A Common Stock | |
| Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 21,605 | 21,605 | - | - | Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 175,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Sherrie L. Perkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 21,605 | 21,605 | - | - | Stock Option (Right to Buy) | |
| Sherrie L. Perkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 6,049 | 6,986 (0%) | 0% | 0 | Class A Common Stock | |
| Jeffrey S. Mathiesen | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 8,011 | 11,948 (0%) | 0% | 0 | Class A Common Stock | |
| Antonella R. Favit-Van Pelt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Mathiesen | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 5.31 per share. | 17 Dec 2021 | 3,000 | 3,937 (0%) | 0% | 5.3 | 15,929 | Class A Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 17 Dec 2021 | 3,825 | 53,779 (0%) | 0% | 5.3 | 20,092 | Class A Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.25 per share. | 17 Dec 2021 | 1,275 | 19,200 (0%) | 0% | 5.3 | 6,697 | Class A Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 12 Nov 2021 | 2,910 | 17,925 (0%) | 0% | 8 | 23,280 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 12 Nov 2021 | 200 | 4,634 (0%) | 0% | 8 | 1,600 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 12 Nov 2021 | 11,430 | 49,954 (0%) | 0% | 8 | 91,440 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 12 Nov 2021 | 22,960 | 86,482 (0%) | 0% | 8 | 183,680 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.72 per share. | 15 Sep 2021 | 1,155 | 15,015 (0%) | 0% | 14.7 | 17,004 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.72 per share. | 15 Sep 2021 | 312 | 4,434 (0%) | 0% | 14.7 | 4,593 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.72 per share. | 15 Sep 2021 | 3,125 | 38,524 (0%) | 0% | 14.7 | 46,007 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.72 per share. | 15 Sep 2021 | 5,408 | 63,522 (0%) | 0% | 14.7 | 79,618 | Common Stock |
| Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 2,547 | 2,547 | - | - | Stock Option (Right to Buy) | |
| Paul R. Buckman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2021 | 721 | 721 (0%) | 0% | 0 | Class A Common Stock | |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.96 per share. | 10 Sep 2021 | 1,155 | 13,860 (0%) | 0% | 15.0 | 17,282 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.96 per share. | 10 Sep 2021 | 312 | 4,122 (0%) | 0% | 15.0 | 4,668 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.96 per share. | 10 Sep 2021 | 3,125 | 35,399 (0%) | 0% | 15.0 | 46,759 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.96 per share. | 10 Sep 2021 | 5,408 | 58,114 (0%) | 0% | 15.0 | 80,919 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.86 per share. | 07 Sep 2021 | 2,407 | 49,461 (0%) | 0% | 14.9 | 35,775 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.83 per share. | 07 Sep 2021 | 3,245 | 52,706 (0%) | 0% | 14.8 | 48,111 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.86 per share. | 07 Sep 2021 | 514 | 12,012 (0%) | 0% | 14.9 | 7,639 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.83 per share. | 07 Sep 2021 | 693 | 12,705 (0%) | 0% | 14.8 | 10,275 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.86 per share. | 07 Sep 2021 | 1,390 | 30,399 (0%) | 0% | 14.9 | 20,659 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.83 per share. | 07 Sep 2021 | 1,875 | 32,274 (0%) | 0% | 14.8 | 27,799 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.86 per share. | 07 Sep 2021 | 139 | 3,623 (0%) | 0% | 14.9 | 2,066 | Common Stock |
| Dane C. Andreeff | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.82 per share. | 07 Sep 2021 | 187 | 3,810 (0%) | 0% | 14.8 | 2,772 | Common Stock |
| Antonella R. Favit-Van Pelt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2021 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 937 | 3,351 (0%) | 0% | 0 | Class A Common Stock | |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 3,063 | 3,063 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 3,063 | 3,063 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 937 | 1,008 (0%) | 0% | 0 | Class A Common Stock | |
| Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 3,063 | 3,063 | - | - | Stock Option (Right to Buy) | |
| Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 937 | 937 (0%) | 0% | 0 | Class A Common Stock | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 937 | 1,508 (0%) | 0% | 0 | Class A Common Stock | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 3,063 | 3,063 | - | - | Stock Option (Right to Buy) | |
| Sherrie L. Perkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 3,063 | 3,063 | - | - | Stock Option (Right to Buy) | |
| Sherrie L. Perkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 937 | 937 (0%) | 0% | 0 | Class A Common Stock | |
| Mitchell E. Tyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 937 | 24,638 (0%) | 0% | 0 | Class A Common Stock | |
| Mitchell E. Tyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 3,063 | 3,063 | - | - | Stock Option (Right to Buy) | |
| Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 2,668 | 12,244 (0%) | 0% | 0 | Class A Common Stock | |
| Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 3,490 | 3,490 | - | - | Employee Stock Option (Right to Buy) | |
| Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 5,337 | 9,576 (0%) | 0% | 0 | Class A Common Stock | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 2,850 | 2,850 | - | - | Warrant (Right to Buy) | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,234 | 3,234 | - | - | Warrant (Right to Buy) | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 14.81 per share. | 01 Feb 2021 | 1,800 | 3,484 (0%) | 0% | 14.8 | 26,658 | Common Stock |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 14.81 per share. | 01 Feb 2021 | 5,700 | 29,009 (0%) | 0% | 14.8 | 84,417 | Common Stock |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 14.81 per share. | 01 Feb 2021 | 2,900 | 11,498 (0%) | 0% | 14.8 | 42,949 | Common Stock |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 14.81 per share. | 01 Feb 2021 | 6,468 | 47,054 (0%) | 0% | 14.8 | 95,791 | Common Stock |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 900 | 900 | - | - | Warrant (Right to Buy) | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 1,450 | 1,450 | - | - | Warrant (Right to Buy) | |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.46 per share. | 21 Oct 2020 | 38,138 | 148,743 (0%) | 0% | 0.5 | 17,616 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2020 | 19,069 | 19,069 | - | - | Warrant (Right to Buy) | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2020 | 185,941 | 185,941 | - | - | Warrant (Right to Buy) | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2020 | 67,436 | 67,436 | - | - | Warrant (Right to Buy) | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2020 | 319,091 | 319,091 | - | - | Warrant (Right to Buy) | |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.46 per share. | 21 Oct 2020 | 37,363 | 58,945 (0%) | 0% | 0.5 | 17,258 | Class A Common Stock |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.46 per share. | 21 Oct 2020 | 371,883 | 815,842 (2%) | 1% | 0.5 | 171,773 | Class A Common Stock |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.46 per share. | 21 Oct 2020 | 134,873 | 300,953 (0%) | 0% | 0.5 | 62,298 | Class A Common Stock |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.46 per share. | 21 Oct 2020 | 638,182 | 1,420,525 (4%) | 2% | 0.5 | 294,776 | Class A Common Stock |
| Dane C. Andreeff | Director, Interim President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2020 | 18,681 | 18,681 | - | - | Warrant (Right to Buy) | |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2020 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jonathan Sackier | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Oct 2020 | 60,000 | 60,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.55 per share. | 31 Jul 2020 | 4,946 | 110,605 (0%) | 0% | 0.6 | 2,745 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.52 per share. | 15 Jul 2020 | 5,312 | 105,659 (0%) | 0% | 0.5 | 2,745 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.43 per share. | 30 Jun 2020 | 6,429 | 100,347 (0%) | 0% | 0.4 | 2,764 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.49 per share. | 15 Jun 2020 | 5,602 | 93,918 (0%) | 0% | 0.5 | 2,745 | Class A Common Stock |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 61,218 | 114,383 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 61,218 | 121,421 | - | - | Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 61,218 | 84,202 | - | - | Stock Option (Right to Buy) | |
| Mitchell E. Tyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 61,218 | 160,424 | - | - | Stock Option (Right to Buy) | |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.49 per share. | 29 May 2020 | 5,557 | 88,316 (0%) | 0% | 0.5 | 2,723 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.50 per share. | 15 May 2020 | 5,501 | 82,759 (0%) | 0% | 0.5 | 2,751 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 15 May 2020 | 53,969 | 782,343 (2%) | 0% | 0.6 | 30,223 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 15 May 2020 | 11,359 | 166,080 (0%) | 0% | 0.6 | 6,361 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 15 May 2020 | 3,052 | 21,582 (0%) | 0% | 0.6 | 1,709 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 15 May 2020 | 31,620 | 443,959 (1%) | 0% | 0.6 | 17,707 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 13 May 2020 | 26,985 | 728,374 (2%) | 0% | 0.6 | 15,112 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.57 per share. | 13 May 2020 | 80,954 | 701,389 (2%) | 0% | 0.6 | 46,144 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.57 per share. | 13 May 2020 | 17,038 | 149,042 (0%) | 0% | 0.6 | 9,712 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.57 per share. | 13 May 2020 | 47,430 | 396,529 (1%) | 0% | 0.6 | 27,035 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.57 per share. | 13 May 2020 | 4,578 | 17,004 (0%) | 0% | 0.6 | 2,609 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 13 May 2020 | 5,679 | 154,721 (0%) | 0% | 0.6 | 3,180 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 13 May 2020 | 15,810 | 412,339 (1%) | 0% | 0.6 | 8,854 | Class A Common Stock |
| Dane C. Andreeff | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 13 May 2020 | 1,526 | 18,530 (0%) | 0% | 0.6 | 855 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.43 per share. | 30 Apr 2020 | 6,399 | 77,258 (0%) | 0% | 0.4 | 2,752 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.43 per share. | 30 Apr 2020 | 9,320 | 90,858 (0%) | 0% | 0.4 | 4,008 | Class A Common Stock |
| Jonathan Sackier | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2020 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.27 per share. | 15 Apr 2020 | 10,167 | 70,859 (0%) | 0% | 0.3 | 2,745 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.27 per share. | 15 Apr 2020 | 14,809 | 81,538 (0%) | 0% | 0.3 | 3,998 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.33 per share. | 31 Mar 2020 | 8,319 | 60,692 (0%) | 0% | 0.3 | 2,745 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.33 per share. | 31 Mar 2020 | 12,117 | 66,729 (0%) | 0% | 0.3 | 3,999 | Class A Common Stock |
| Jonathan Sackier | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2020 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.47 per share. | 13 Mar 2020 | 5,841 | 52,373 (0%) | 0% | 0.5 | 2,745 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.47 per share. | 13 Mar 2020 | 8,507 | 54,612 (0%) | 0% | 0.5 | 3,998 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.91 per share. | 28 Feb 2020 | 3,016 | 46,532 (0%) | 0% | 0.9 | 2,745 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.91 per share. | 28 Feb 2020 | 4,394 | 46,105 (0%) | 0% | 0.9 | 3,999 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.85 per share. | 14 Feb 2020 | 3,229 | 43,516 (0%) | 0% | 0.9 | 2,745 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.85 per share. | 14 Feb 2020 | 4,704 | 41,711 (0%) | 0% | 0.8 | 3,998 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 1.01 per share. | 31 Jan 2020 | 2,718 | 40,287 (0%) | 0% | 1.0 | 2,745 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.01 per share. | 31 Jan 2020 | 3,959 | 37,007 (0%) | 0% | 1.0 | 3,999 | Class A Common Stock |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 15 Jan 2020 | 2,639 | 37,569 (0%) | 0% | 1.0 | 2,745 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 1.04 per share. | 15 Jan 2020 | 3,844 | 33,048 (0%) | 0% | 1.0 | 3,998 | Class A Common Stock |
| Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.97 per share. | 31 Dec 2019 | 2,830 | 34,930 (0%) | 0% | 1.0 | 2,745 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.97 per share. | 31 Dec 2019 | 4,122 | 29,204 (0%) | 0% | 1.0 | 3,998 | Class A Common Stock |
| Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.44 per share. | 13 Dec 2019 | 6,239 | 32,100 (0%) | 0% | 0.4 | 2,745 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.44 per share. | 13 Dec 2019 | 9,087 | 25,082 (0%) | 0% | 0.4 | 3,998 | Class A Common Stock |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| R. Blane Walter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| R. Blane Walter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Joyce N. LaViscount | CFO and COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 150,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Joyce N. LaViscount | CFO and COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 20,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 20,000 | 20,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Joyce N. LaViscount | CFO and COO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 120,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 120,000 | 120,000 | - | - | Employee Stock Option (Right to Buy) | |
| Huaizheng Peng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Huaizheng Peng | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Huaizheng Peng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Huaizheng Peng | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Thomas E. Griffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Thomas E. Griffin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 300,000 | 300,000 | - | - | Employee Stock Option (Right to Buy) | |
| Philippe Deschamps | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 300,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Jonathan Sackier | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 80,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Jonathan Sackier | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jonathan Sackier | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 07 Dec 2019 | 120,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Jonathan Sackier | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Dec 2019 | 120,000 | 120,000 | - | - | Employee Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 27 Nov 2019 | 187,946 | 349,099 (1%) | 0% | 0.3 | 65,781 | Class A Common Stock |
| Dane C. Andreeff | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 27 Nov 2019 | 317,762 | 620,435 (2%) | 1% | 0.4 | 111,217 | Class A Common Stock |
| Dane C. Andreeff | Director | Grant, award, or other acquisition of securities at price $ 0.35 per share. | 27 Nov 2019 | 65,721 | 132,004 (0%) | 0% | 0.3 | 23,002 | Class A Common Stock |
| Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Oct 2019 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| Philippe Deschamps | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.60 per share. | 05 Apr 2019 | 5,018 | 15,995 (0%) | 0% | 5.6 | 28,101 | Class A Common Stock |
| Philippe Deschamps | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2019 | 5,018 | 0 | - | - | Warrant (Right to Buy) | |
| R. Blane Walter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 18,990 | 18,990 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 16,218 | 16,218 | - | - | Stock Option (Right to Buy) | |
| Joyce N. LaViscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Dane C. Andreeff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 17,901 | 17,901 | - | - | Stock Option (Right to Buy) | |
| Huaizheng Peng | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 15,525 | 15,525 | - | - | Stock Option (Right to Buy) | |
| Thomas E. Griffin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 18,891 | 18,891 | - | - | Stock Option (Right to Buy) | |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 160,000 | 160,000 | - | - | Employee Stock Option (Right to Buy) | |
| Jonathan Sackier | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| Mitchell E. Tyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2019 | 14,733 | 14,733 | - | - | Stock Option (Right to Buy) | |
| Jennifer Laux | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2018 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Dane C. Andreeff | None | Purchase of securities on an exchange or from another person at price $ 10.10 per share. | 25 Jun 2018 | 304 | 326,251 (1%) | 0% | 10.1 | 3,070 | Class A Common Stock |
| Dane C. Andreeff | None | Purchase of securities on an exchange or from another person at price $ 10.11 per share. | 25 Jun 2018 | 817 | 792,703 (3%) | 0% | 10.1 | 8,260 | Class A Common Stock |
| Dane C. Andreeff | None | Purchase of securities on an exchange or from another person at price $ 10.10 per share. | 25 Jun 2018 | 1,379 | 1,489,932 (6%) | 0% | 10.1 | 13,928 | Class A Common Stock |
| Dane C. Andreeff | None | Purchase of securities on an exchange or from another person at price $ 10.11 per share. | 25 Jun 2018 | 304 | 326,555 (1%) | 0% | 10.1 | 3,073 | Class A Common Stock |
| Dane C. Andreeff | None | Purchase of securities on an exchange or from another person at price $ 10.11 per share. | 25 Jun 2018 | 1,379 | 1,491,311 (6%) | 0% | 10.1 | 13,942 | Class A Common Stock |
| Dane C. Andreeff | None | Purchase of securities on an exchange or from another person at price $ 10.10 per share. | 25 Jun 2018 | 817 | 791,886 (3%) | 0% | 10.1 | 8,252 | Class A Common Stock |
| Dane C. Andreeff | None | Purchase of securities on an exchange or from another person at price $ 10.10 per share. | 25 Jun 2018 | 2,757 | 1,488,553 (6%) | 0% | 10.1 | 27,846 | Class A Common Stock |
| Dane C. Andreeff | None | Purchase of securities on an exchange or from another person at price $ 10.10 per share. | 25 Jun 2018 | 609 | 325,947 (1%) | 0% | 10.1 | 6,151 | Class A Common Stock |
| Dane C. Andreeff | None | Purchase of securities on an exchange or from another person at price $ 10.10 per share. | 25 Jun 2018 | 1,634 | 791,069 (3%) | 0% | 10.1 | 16,503 | Class A Common Stock |
| R. Blane Walter | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Edward M. Straw | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Joyce N. Laviscount | CFO and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Buy) | |
| Dane C. Andreeff | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Huaizheng Peng | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Thomas E. Griffin | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Philippe Deschamps | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2018 | 95,000 | 95,000 | - | - | Employee Stock Option (Right to Buy) | |
| Thomas E. Griffin | None | Purchase of securities on an exchange or from another person at price $ 7.47 per share. | 13 Apr 2018 | 3,346 | 3,346 (0%) | 0% | 7.5 | 24,995 | Class A Common Stock |
| Thomas E. Griffin | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Apr 2018 | 3,346 | 3,346 | - | - | Warrant (Right to Buy) | |
| Jonathan Sackier | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 15 Mar 2018 | 62,002 | 703,403 (3%) | 0% | 0 | Class A Common Stock | |
| Jonathan Sackier | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2018 | 80,000 | 80,000 | - | - | Employee Stock Option (Right to Buy) | |
| Mitchell E. Tyler | None | Other type of transaction at price $ 0.00 per share. | 10 Jan 2018 | 829,545 | 829,545 (0%) | 0% | 0 | Class A Common Stock | |
| Mitchell E. Tyler | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2018 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) |